Targeted therapy of atherosclerosis by pH-sensitive hyaluronic acid nanoparticles co-delivering all-trans retinal and rapamycin

A smart nanoplatform based on hyaluronic acid was developed for targeted atherosclerosis combination therapy, which effectively attenuated the progression of the plaque by simultaneously reducing inflammation and oxidative stress at the aortic lesion.